Search
for
Sort by
Research 181–210 of 1000+
- Citrullination at the Inflammatory Skin Barrier
- Successful treatment of alopecia universalis with abrocitinib: a case report
- Spotlight in Plastic Surgery: October 2022
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Upadacitinib for the treatment of alopecia areata – A case report
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata
- Upadacitinib: A New Weapon for the Treatment of Twenty-Nail Dystrophy
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias
- Management of comorbid Crohn's disease and alopecia universalis with upadacitinib and oral minoxidil.
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- 802 Molecular effect of brepocitinib in hidradenitis suppurativa (HS)
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- JAK Inhibitors in African American Patients With Alopecia Areata: A Case Series
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- 865 Conditional ablation of JAK-STAT5 signaling induces anagen hair growth
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review